Palliative Care Facilitated Access List
The Palliative Care Facilitated Access List ("PCFA List") is maintained by the Ontario Medical Association ("OMA") and shared with Ministry of Health and Long-Term Care, the Ontario Drug Benefit (ODB) program and Ontario pharmacists for purposes described below. Physicians who wish to be added to the PCFA List must meet one or more of the criteria in the declaration below.
Specific products used to treat ODB-eligible patients undergoing palliative (end-of-life) care are reimbursed through the Facilitated Access (FA) process under the Exceptional Access Program (EAP) of the Ontario Drug Benefit (ODB) Act. Under this process, physicians on the PCFA List are exempt from the usual paperwork associated with the provision of these products (i.e. exempt from obtaining approval under the EAP on a case by case basis).
Palliative care medication claims to be reimbursed under the ODB program must be prescribed in accordance with the following patient eligibility criteria: The patient has a progressive, life-limiting illness and requires the requested medication for symptom management.
To facilitate the reimbursement process at the pharmacy, the prescriber is asked to indicate either, “Palliative” or “P.C.F.A.”, on the prescription to signify that the patient meets the above-noted eligibility criteria. This would be an indication to the pharmacist that these medications may be reimbursed under this mechanism. The physician’s College of Physicians and Surgeons of Ontario registration number must also appear on the prescription for purposes of verification.
A list of products eligible for reimbursement through the FA is maintained by the ODB and can be found here: ODB Formulary/Comparative Drug Index. Please see section VI-B.